US Patent

US8088368 — Antiviral compounds

Composition of Matter · Assigned to Gilead Sciences Inc · Expires 2030-05-12 · 4y remaining

Vulnerability score 10/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects antiviral compounds, compositions containing them, and methods for preparing and using these compounds.

USPTO Abstract

The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

Drugs covered by this patent

Patent Metadata

Patent number: US8088368
Jurisdiction: US
Classification: Composition of Matter
Expires: 2030-05-12
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Gilead Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.